Feb. 27, 2023 – The study was further carried out by the Scripps Research Institute in La Jolla, California. They then started human trials for the drug. Their study involved 51 subjects who were assessed over 11 days after they went under treatment with this particular drug.
Barbara Mason, a co-author of the study from the Scripps Research Institute team, told the Oregon Health and Science University Press, “Apremilast’s large effect size on reducing drinking, combined with its good tolerability in our participants, suggests it is an excellent candidate for further evaluation as a novel treatment for people with alcohol use disorder.”
Meanwhile, Mason anticipates that the medication may be even more beneficial for people who are motivated to cut back on their alcohol consumption. The study was conducted with subjects who had alcohol disorders, but were not seeking any kind of treatment.
GIVING BACK IN STYLE – April 17, 2024 - “It’s still one day at…
RIDING THE WAVE...CALMLY – April 18, 2024 - “I was 13 years old and…
VIDEO – NEW YORK STORIES – April 23, 2024 - Sara Gettelfinger had steadily…
TRY IT, YOU’LL LIKE IT – April 18, 2024 - The rise in “sober…
AUDIO – SOBER MEN CAN DO THAT – April 4, 2024 - Acting icon…
I’LL BET HE GOES TO GA (not Georgia) – April 13, 2024 -The initial…